Skip to main content
  • genomeweb
  • 360dx
360Dx
  • RSS Feeds
  • Twitter
  • LinkedIn
  • Forgot your password?
  • Subscribe
  • Business & Policy
      • Business News
      • Research Funding
      • Policy & Legislation
      • Regulatory News
      • Reimbursement
  • Clinical Lab Management
  • Diagnostics
      • Molecular Diagnostics
      • Immunoassays
      • Tissue-Based Testing
      • Clinical Chemistry
      • Hematology/Coagulation
      • Point-of-Care Testing
      • Companion Diagnostics
  • Disease Areas
      • Cancer
      • Infectious Disease
      • Cardiovascular Disease
      • Neurological & Psychological Disease
      • Autoimmune Disease
      • Inherited Disease
      • Reproductive Health
      • Respiratory
      • Gastrointestinal
  • Resources
      • Webinars
      • White Papers
      • Job Listings
      • New Products
      • People in the News
      • Conferences & Events

Main menu

Home › Abbott HbA1c Test FDA Cleared to Diagnose Diabetes

Abbott HbA1c Test FDA Cleared to Diagnose Diabetes

Jun 21, 2018

NEW YORK (360Dx) – Abbott said on Thursday that the US Food and Drug Administration has cleared the company's Afinion HbA1c Dx assay to help diagnose diabetes mellitus and assess a patient's risk of developing the disease.

The rapid point-of-care assay was cleared to run on Abbott's Afinion AS100 Analyzer.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Breaking News

  • Startup Cadex Genomics Raises $1.5M

  • All Breast Cancer Patients Should Receive Multigene Panel Tests, Surgeon Group Says

  • In Brief This Week: BioDirection, Quest Diagnostics, OncoCyte, and More

  • Jefferies Initiates Coverage of CareDx With Buy Rating

  • Decipher Biosciences, Dendreon Pharmaceuticals Ink Prostate Cancer Research Deal

  • Bio-Rad Clinical ddPCR Test, Diagnostic System Get FDA Clearance

What's Popular?

In Regulatory News
  1. Bio-Rad Clinical ddPCR Test, Diagnostic System Get FDA Clearance

  2. Hologic Aptima HIV-1 Assay Receives Dual Claim CE Marking

  3. Bioneer HIV-1 Dx Kit Gets Korea FDA Approval

  4. GenomeDx Biosciences to Pay $2M to Settle Allegations of Improper Medicare Billing

  5. Q&A: OIR Director Timothy Stenzel Discusses Precision Medicine Efforts During First Year at FDA

    Premium

Sponsorships

  • About Us
  • Advertise
  • Contact
  • Jobs
  • Sitemap
Subscribe

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.